TrialInternational urology and nephrology2021

Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity.

Jan Krhut et al.PubMed ↗Publisher ↗

No numbers read from the abstract.